Kintara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTRA and other ETFs, options, and stocks.About KTRA
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001.
CEORobert E. Hoffman
CEORobert E. Hoffman
Employees17
Employees17
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2009
Founded2009
Employees17
Employees17
KTRA Key Statistics
Market cap8.78M
Market cap8.78M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume10.39M
Average volume10.39M
High today$0.1617
High today$0.1617
Low today$0.143
Low today$0.143
Open price$0.1472
Open price$0.1472
Volume3.49M
Volume3.49M
52 Week high$5.98
52 Week high$5.98
52 Week low$0.081
52 Week low$0.081